Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-16
DOI
10.1038/s41409-018-0302-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Feasibility and Toxicity of Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)
- (2018) Gunjan L. Shah et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pharmacokinetics and Toxicities after Evomela® (Propylene Glycol Free Melphalan) with Hematopoietic Stem Cell Transplant (HCT) for Multiple Myeloma (MM), AL Amyloidosis (AL), Lymphoma, Acute Myeloid Leukemia (AML), and Myelodysplastic Syndrome (MDS)
- (2018) Gunjan L. Shah et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pharmacokinetics of High-Dose Propylene Glycol–Free Melphalan in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation
- (2018) Binod Dhakal et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective
- (2018) Talha Badar et al. BONE MARROW TRANSPLANTATION
- Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma
- (2018) Morie A. Gertz et al. MAYO CLINIC PROCEEDINGS
- The multiple myelomas — current concepts in cytogenetic classification and therapy
- (2018) Shaji K. Kumar et al. Nature Reviews Clinical Oncology
- Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
- (2017) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation
- (2016) Christa E. Nath et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Multiple Myeloma: Diagnosis and Treatment
- (2016) S. Vincent Rajkumar et al. MAYO CLINIC PROCEEDINGS
- A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
- (2015) Parameswaran Hari et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Phase IIa cross-over study of propylene glycol-free melphalan (LGD-353) and alkeran in multiple myeloma autologous transplantation
- (2014) O S Aljitawi et al. BONE MARROW TRANSPLANTATION
- The Choice of Multiple Myeloma Induction Therapy Affects the Frequency and Severity of Oral Mucositis After Melphalan-Based Autologous Stem Cell Transplantation
- (2014) Shaun Fleming et al. Clinical Lymphoma Myeloma & Leukemia
- Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma
- (2014) Chintan Pandya et al. CLINICAL TRANSPLANTATION
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
- (2014) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Fifty Years of Melphalan Use in Hematopoietic Stem Cell Transplantation
- (2012) Ulas D. Bayraktar et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Lymphoma-associated hemophagocytic lymphohistiocytosis
- (2012) O. S. Aljitawi et al. BLOOD
- Economics of hematopoietic cell transplantation
- (2012) N. Khera et al. BLOOD
- Melphalan-Induced Supraventricular Tachycardia: Incidence and Risk Factors
- (2011) Victor Feliz et al. CLINICAL CARDIOLOGY
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical comparison of intravenous melphalan pharmacokinetics administered in formulations containing either (SBE)7 m-β-cyclodextrin or a co-solvent system
- (2010) Maria Koltun et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies
- (2008) Jeffrey A. Jones et al. CANCER
- Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
- (2008) R A Kyle et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now